SAVA Q2 2020 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$591,000

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-0.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$842,000

Free Cash Flow

-$842,000

Stock-Based Comp.

$252,000

Balance Sheet

Total Assets

$25M

Total Liabilities

$1M

Stockholders' Equity

$24M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$591,000	-$308	-191783.1%
Operating Income	-$1M	-$1M	-0.9%
Net Income	-$1M	-$1M	-7.3%